Lilly’s weight loss pill succeeds in late stage trial; Novo acquires a new drug; Pfizer on U.S.-China partnerships.

As researchers scramble to develop compounds that will be even safer and more effective for weight loss than currently ...

Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...

People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...

Eli Lilly's experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage ...

Eli Lilly said on Wednesday its experimental pill, orforglipron, helped reduce blood sugar levels in two late-stage trials.

The newer generation of glucose-lowering agents, such as GLP-1 receptor agonists, enable many patients to reach glycaemic treatment goals, with cardiovascular risk reduction, and the additional ...

Eli Lilly (NYSE: LLY) has been one of the best-performing healthcare giants over the past decade. It now stands as the ...

Over the past decade, Eli Lilly (LLY) has grown into the highest-valued company in the healthcare sector by market ...

A doctor has broken down what happens on a week-by-week basis when you start taking GLP-1 drugs like Wegovy and Mounjaro and ...